Portal:Nanomaterials/News
From WikiPathways
(Difference between revisions)
Line 1: | Line 1: | ||
+ | * '''2016-08-31''' - A new pathway was added: "Nanomaterial induced inflammasome activation (Homo sapiens)" ([[Pathway:WP3890]]) | ||
* '''2016-04-04''' - A new pathway was added: "Lung fibrosis (Homo sapiens)" ([[Pathway:WP3624]]) | * '''2016-04-04''' - A new pathway was added: "Lung fibrosis (Homo sapiens)" ([[Pathway:WP3624]]) | ||
* '''2015-07-17''' - A new pathway was added: "Overview of nanoparticle effects" ([[Pathway:WP3287]]) | * '''2015-07-17''' - A new pathway was added: "Overview of nanoparticle effects" ([[Pathway:WP3287]]) | ||
* '''2014-04-04''' - A new pathway was added: "Nanoparticle-mediated activation of receptor signaling" ([[Pathway:WP2643]]) | * '''2014-04-04''' - A new pathway was added: "Nanoparticle-mediated activation of receptor signaling" ([[Pathway:WP2643]]) | ||
* '''2014-02-19''' - This portal is a currently in alpha mode, meaning that it is a draft of what it will look like, and now exists to recruit two or three editors. | * '''2014-02-19''' - This portal is a currently in alpha mode, meaning that it is a draft of what it will look like, and now exists to recruit two or three editors. |
Revision as of 13:30, 31 August 2016
- 2016-08-31 - A new pathway was added: "Nanomaterial induced inflammasome activation (Homo sapiens)" (Pathway:WP3890)
- 2016-04-04 - A new pathway was added: "Lung fibrosis (Homo sapiens)" (Pathway:WP3624)
- 2015-07-17 - A new pathway was added: "Overview of nanoparticle effects" (Pathway:WP3287)
- 2014-04-04 - A new pathway was added: "Nanoparticle-mediated activation of receptor signaling" (Pathway:WP2643)
- 2014-02-19 - This portal is a currently in alpha mode, meaning that it is a draft of what it will look like, and now exists to recruit two or three editors.